Covid-19 vaccines: safety surveillance manual - Communication

Overview

Communication about COVID-19 vaccine safety will play a key role in maintaining the public’s confidence in vaccination. Effective communication will require planning and resources, which need to be in place as early as possible before COVID-19 vaccines are available.

This module provides guidance on communicating about COVID-19 vaccine safety from a programme perspective. It includes:

- a description of factors that influence people’s perceptions of vaccine safety,

- case studies of past experiences with previous pandemics and vaccine safety issues,

- a synthesis of evidence and recommendations for communication from risk communication,

- hypothetical scenarios that apply these recommendations to the COVID-19 vaccine context, and

- criteria for prioritizing responses to vaccine safety issues.

WHO Team
Pharmacovigilance (PVG), Regulation and Prequalification (RPQ)
Number of pages
56
Reference numbers
WHO Reference Number: WHO/MHP/RPQ/PVG/2021.6
Copyright
CC BY-NC-SA 3.0 IGO